IBUPROHM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ibuprohm, and when can generic versions of Ibuprohm launch?
Ibuprohm is a drug marketed by Ohm Labs and is included in three NDAs.
The generic ingredient in IBUPROHM is ibuprofen; pseudoephedrine hydrochloride. There are sixty-four drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ibuprofen; pseudoephedrine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ibuprohm
A generic version of IBUPROHM was approved as ibuprofen; pseudoephedrine hydrochloride by DR REDDYS LABS LTD on August 14th, 2006.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for IBUPROHM?
- What are the global sales for IBUPROHM?
- What is Average Wholesale Price for IBUPROHM?
Summary for IBUPROHM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 207 |
| Patent Applications: | 4,329 |
| DailyMed Link: | IBUPROHM at DailyMed |
US Patents and Regulatory Information for IBUPROHM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ohm Labs | IBUPROHM | ibuprofen | TABLET;ORAL | 071214-001 | Dec 1, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ohm Labs | IBUPROHM | ibuprofen | TABLET;ORAL | 070469-001 | Aug 29, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ohm Labs | IBUPROHM COLD AND SINUS | ibuprofen; pseudoephedrine hydrochloride | TABLET;ORAL | 074567-001 | Apr 17, 2001 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
EU/EMA Drug Approvals for IBUPROHM
| Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
|---|---|---|---|---|---|---|---|---|---|
| Recordati Rare Diseases | Pedea | ibuprofen | EMEA/H/C/000549 Treatment of a haemodynamically significant patent ductus arteriosus in preterm newborn infants less than 34 weeks of gestational age. |
Authorised | no | no | no | 2004-07-28 | |
| >Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
